Vincerx Pharma Inc. (VINC) NASDAQ

$1.60 -0.03 (-1.84%)

Market Cap: $33.90M

As of 08/16/22 04:30 PM EDT. Market closed.

(VINC)

Vincerx Pharma Inc. (VINC) NASDAQ

$1.60 -0.03 (-1.84%)

Market Cap: $33.90M

As of 08/16/22 04:30 PM EDT. Market closed.

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating ... read more

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company intends to develop multiple products through clinical proof-of-concept and potentially through Accelerated Approval in the United States. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
28
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$1.63
Days Range
$1.57 - $1.66
52 week range
$1.26 - $18.43
Volume
0
Avg. Volume (30 days)
113,571
Market Cap
$33.90M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,189,769
Open
$0
Previous Close
$1.63
Days Range
$1.57 - $1.66
52 week range
$1.26 - $18.43
Volume
0
Avg. Volume (30 days)
113,571
Market Cap
$33.90M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,189,769

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VINCERX PHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Izumi Raquel E. See Remarks Jun 27, 2022 Buy $1.41 40,000 56,312 40,000 Jun 29, 2022, 04:05 PM
Hamdy Ahmed MD Chief Executive Officer Jun 23, 2022 Buy $1.41 24,200 34,137 38,480 Jun 27, 2022, 07:20 PM
Bushnell Laura I. Director Jun 09, 2022 Buy $1.91 15,000 28,625 19,202 Jun 13, 2022, 08:01 PM
THOMAS TOM C See Remarks Dec 22, 2021 Buy $10.23 1,000 10,230 3,000 Dec 27, 2021, 04:48 PM
Hwang Sooin Chief Business Officer Dec 23, 2021 Buy $10.00 3,000 30,000 390,491 Dec 27, 2021, 04:42 PM
Bushnell Laura I. Director Dec 22, 2021 Buy $10.48 2,402 25,173 4,202 Dec 27, 2021, 04:39 PM
Seelenberger Alexander A. Chief Financial Officer Dec 22, 2021 Buy $10.34 2,417 24,988 12,493 Dec 27, 2021, 04:34 PM
Hamdy Ahmed MD Chief Executive Officer Dec 22, 2021 Buy $10.02 6,450 64,650 14,280 Dec 27, 2021, 04:28 PM
Izumi Raquel E. See Remarks Aug 04, 2021 Buy $11.96 1,000 11,960 1,000 Aug 06, 2021, 04:45 PM
Lee John H. Director Jun 29, 2021 Buy $12.72 799 10,159 799 Jul 01, 2021, 06:52 PM
McDonald Andrew I Director Jun 29, 2021 Buy $12.38 20,000 247,600 20,000 Jul 01, 2021, 06:05 AM
Hamdy Ahmed MD Chief Executive Officer Jun 29, 2021 Buy $12.77 7,830 99,989 7,830 Jun 30, 2021, 07:02 PM
Bushnell Laura I. Director Jun 30, 2021 Buy $12.94 1,800 23,297 1,800 Jun 30, 2021, 07:02 PM
Seelenberger Alexander A. Chief Financial Officer Jun 29, 2021 Buy $12.61 7,950 100,260 7,950 Jun 30, 2021, 06:59 PM
LOWE CHRISTOPHER P. Director Jun 30, 2021 Buy $12.66 3,600 45,576 10,000 Jun 30, 2021, 06:59 PM
LOWE CHRISTOPHER P. Director Jun 29, 2021 Buy $12.59 6,400 80,576 6,400 Jun 30, 2021, 06:59 PM
THOMAS TOM C See Remarks Jun 29, 2021 Buy $12.58 2,000 25,160 2,000 Jun 30, 2021, 06:57 PM
Hwang Sooin Chief Business Officer Jun 30, 2021 Buy $12.66 500 6,330 385,575 Jun 30, 2021, 06:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Izumi Raquel E. See Remarks 06/27/2022 56,312
Hamdy Ahmed MD Chief Executive Officer 06/23/2022 34,137
Bushnell Laura I. Director 06/09/2022 28,625
THOMAS TOM C See Remarks 12/22/2021 10,230
Hwang Sooin Chief Business Officer 12/23/2021 30,000
Bushnell Laura I. Director 12/22/2021 25,173
Seelenberger Alexander A. Chief Financial Officer 12/22/2021 24,988
Hamdy Ahmed MD Chief Executive Officer 12/22/2021 64,650
Izumi Raquel E. See Remarks 08/04/2021 11,960
Lee John H. Director 06/29/2021 10,159
McDonald Andrew I Director 06/29/2021 247,600
Hamdy Ahmed MD Chief Executive Officer 06/29/2021 99,989
Bushnell Laura I. Director 06/30/2021 23,297
Seelenberger Alexander A. Chief Financial Officer 06/29/2021 100,260
LOWE CHRISTOPHER P. Director 06/30/2021 45,576
LOWE CHRISTOPHER P. Director 06/29/2021 80,576
THOMAS TOM C See Remarks 06/29/2021 25,160
Hwang Sooin Chief Business Officer 06/30/2021 6,330
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
12/31/2021
21.95%
2Q
06/30/2022
09/30/2021
31.40%
3Q
06/30/2022
06/30/2021
39.18%
4Q

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
21.95%
2Q
09/30/2021
31.40%
3Q
06/30/2021
39.18%
4Q